Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
428.9 USD | -0.23% | +4.43% | +5.29% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.29% | 111B | |
+12.24% | 105B | |
-12.53% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-11.09% | 16.96B | |
+5.15% | 13.7B | |
+36.95% | 12.45B | |
+289.74% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q2 2019 Earnings Call, Jul 31, 2019